|
인쇄하기
취소
|
New drug R&D investment by conglomerates near to reap.
Published: 2001-06-25 07:00:00
Updated: 2001-06-25 07:00:00
Many conglomerates who entered into the pharmaceutical business seem to harvest soon their investment for an R&D of new drug discovery.
LG, SK and Cheiljedang already committed their technology exports of new drugs to foreign multinational drug corporations, and now, Kolon announced on June 19 that an anti-arthritis drug was successfully developed by the bio-engineering technology.
They p...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.